Consider any unexplained dips in Hims & Hers Health (HIMS) as a potential buying opportunity, as it is presented as a top conviction play disrupting traditional healthcare. Similarly, recent weakness in AI company Nebius (NBIS) could be an entry point, driven by its explosive revenue guidance and valuable underlying assets. For a leveraged play on Bitcoin, watch MicroStrategy (MSTR) for a potential entry if the stock drops to the $360 level. The core thesis behind these ideas is a long-term bullish conviction in Bitcoin as a fundamental holding to protect against currency devaluation. Investors should focus on these long-term growth stories while being prepared for significant short-term volatility.

MicroStrategy (MSTR)

• The stock was down 7% on the day of the podcast. The speaker attributes this drop to a "sell the news" event following rumors and news about the company's potential inclusion in the S&P 500.
• The speaker advises investors to "zoom out" and look at the long-term performance, noting he was buying the stock in the $20-$30 range years ago.
• The drop is seen as a short-term trading event, not a change in the long-term investment thesis.
• Due to new accounting standards, the company is expected to report its Bitcoin holdings at market value, which could be between $11 billion and $14 billion. This news has already been priced in by short-term traders who are now taking profits.
• The stock sold off much more significantly than Bitcoin itself, which was only down about 1.6%.

Takeaways

• The speaker is bullish on MSTR for the long term and is not worried about the short-term volatility.
• He views the stock as a leveraged play on Bitcoin.
• Actionable Level: The speaker stated he would be a buyer if the stock drops to $360 or below, indicating this could be a level for interested investors to watch.

Bitcoin (BTC)

• Bitcoin was down about 1.5% - 1.6%, a relatively small move compared to some growth stocks.
• The speaker notes that Bitcoin's volatility is decreasing and sometimes moves less than the NASDAQ, suggesting the asset is maturing.
• The speaker holds a strong conviction that Bitcoin is the solution to the debasement of the US dollar and the growing national debt.
• He references Michael Saylor's (CEO of MicroStrategy) original thesis from 2020, which was to buy Bitcoin as a response to the macroeconomic environment.
• The speaker suggests that Tesla should use its large cash position (around $35 billion) to buy more Bitcoin.

Takeaways

• The sentiment is extremely bullish. Bitcoin is presented as a fundamental long-term holding to protect against currency devaluation.
• The decreasing volatility is seen as a positive sign that the asset is gaining wider acceptance and stability.

Tesla (TSLA)

• The stock was down 5% on the day, which the speaker attributes to negative headlines from Elon Musk's public disputes.
• The speaker owns a "fully built position" and is not selling, criticizing those who make emotional decisions based on short-term news.
• Tesla is described as a "headline driven stock", making it very volatile in the short term.
• Upcoming Risk: The speaker warns of potential negative headlines around the upcoming delivery numbers, suggesting the media will likely spin them negatively regardless of the actual results.
• The long-term bullish case is based on the company's strong fundamentals and its position to win in its core market and in "real world AI". The speaker believes the company's foundation is strong enough to withstand leadership controversies, similar to Microsoft under Steve Ballmer.

Takeaways

• The speaker is annoyed with the short-term volatility but remains bullish on the long-term prospects of the company itself.
• Investors should be prepared for significant volatility driven by news headlines.
• Warning: The speaker explicitly advises investors to be "careful with options" on Tesla due to its unpredictable, headline-driven nature.

Hims & Hers Health (HIMS)

• The stock was down 4% after being down as much as 7% at the market open for no apparent reason or negative news.
• The speaker dismisses fears of a potential lawsuit related to semaglutide, citing research from another creator ("Hymn's House") suggesting a suit is unlikely.
• The speaker is extremely bullish on HIMS, calling it the position he is "most confident on".
• He sees the company as a "zero to one" disruptor at the "heart of the disruption of traditional healthcare."
• Key strengths highlighted include its vertically integrated model (telehealth, pharmacy, manufacturing, marketing) and its ability to offer services at a lower cost than going through insurance.
• The company's growth has been accelerating over the past three quarters, moving from a 50% growth rate to the 60-70% range, driven partly by GLP-1 weight-loss drugs.

Takeaways

• The sentiment is exceptionally bullish. The speaker views any unexplained dips as potential buying opportunities.
• The investment thesis is based on the company's disruptive business model and accelerating revenue growth.
• The speaker believes the market's intense focus and volatility around HIMS is a positive sign ("Volatility is vitality"), as it attracts capital and attention to a disruptive company.

Nebius (NBIS)

• The stock was down 9%, erasing its gains from the previous five days and returning to the $50 level.
• The speaker used this drop as an opportunity to add to his position by purchasing LEAPS (long-term options).
• Valuation: The speaker believes the valuation is "not that bad" given the excitement in the AI sector and the company's assets.
• Key Strengths:
  • Management: Led by the founder of Yandex (the "Google of Russia"), which is seen as a "big tech-level management team."
  • Strategic Investments:
    • Owns 28% of ClickHouse, a popular database solution with a reported valuation of $6 billion (and potentially much higher).
    • Owns AVRide, considered a "top 10 autonomous company," which the speaker views as a free hedge on the self-driving industry. He believes this value is not reflected in the stock price.
• Primary Bull Case: The company's outstanding revenue guidance. They are guiding for $600 million in revenue for 2025, a massive increase from the $161 million in trailing 12-month revenue reported in Q1.

Takeaways

• The sentiment is very bullish, driven by explosive growth guidance and valuable hidden assets.
• The speaker sees dips as buying opportunities and will "buy more" if the stock drops further.
• The investment is a play on a high-growth company in the AI sector with strong management and valuable assets (ClickHouse, AVRide) that may be undervalued by the market.